Patent Assignment
Reel/Frame 022769/0131
Assignment of Assignor's Interest
Recorded: 2009-06-01
Pages: 3
Assignor
F. HOFFMANN-LA ROCHE AG
Executed: 2009-05-05
Assignee
HOFFMAN-LA ROCHE, INC.
340 KINGLAND STREET, NUTLEY, NEW JERSEY, 07110
Covered Property
(1)
Combination Therapy of a Type Ii Anti-CD20 Antibody with Increased Antibody Dependent Cellular Cytotoxicity (Adcc)
Application:
12/408,746 →
Publication:
US 2009/0246197
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 1, 2009
From: DUMONTET, CHARLES
To: F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY
Reel/Frame 022769/0108 →
Assignment of Assignor's Interest
Jun 1, 2009
From: UMANA, PABLO
To: GLYCART BIOTECHNOLOGY AG, A SWISS COMPANY
Reel/Frame 022769/0147 →
Assignment of Assignor's Interest
Jun 1, 2009
From: FRIESS, THOMAS; HERTING, FRANK; KLEIN, CHRISTIAN
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 022771/0507 →
Assignment of Assignor's Interest
May 27, 2010
From: HOFFMANN-LA ROCHE INC.
To: ROCHE GLYCART AG
Reel/Frame 024464/0418 →
Change of Name
Jun 29, 2010
From: GLYCART BIOTECHNOLOGY AG
To: ROCHE GLYCART AG
Reel/Frame 024624/0566 →